Yes, oral cephalexin 500 mg every 6 hours for 7-10 days is an appropriate and guideline-recommended treatment for cellulitis of the toe in this patient.
Cephalexin is explicitly recommended by IDSA guidelines as a first-line antibiotic for typical cellulitis without systemic signs of infection, and the FDA label supports 500 mg every 6 hours for skin and skin structure infections 1, 2.
Rationale for This Regimen
Guideline Support
The 2014 IDSA guidelines clearly state that typical cases of cellulitis without systemic signs should receive an antimicrobial agent active against streptococci, with cephalexin specifically listed as an appropriate choice 1. Since your patient has localized toe cellulitis without mention of systemic symptoms (fever, hypotension, altered mental status), this represents a "mild nonpurulent" infection suitable for outpatient oral therapy 1.
Dosing Considerations
- The FDA label approves 500 mg every 12 hours for skin and skin structure infections 2
- However, 500 mg every 6 hours (four times daily) is also FDA-approved and may be preferable for more severe infections or less susceptible organisms 2
- Your proposed every-6-hour dosing provides higher drug exposure and better PK/PD target attainment, particularly important for moderate infections 3, 4
Duration of Therapy
The IDSA guidelines recommend 5 days of therapy if clinical improvement occurs, with extension if needed 1. Your proposed 7-10 day duration aligns with this recommendation and provides flexibility based on clinical response. The FDA label supports treatment courses in this range 2.
Important Clinical Considerations
Examine the Toe Web Spaces
The IDSA guidelines specifically emphasize examining interdigital toe spaces for fissuring, scaling, or maceration 1. Treating concurrent tinea pedis or other toe web abnormalities can eradicate colonization and reduce recurrence risk. This is particularly relevant for toe cellulitis.
When MRSA Coverage Would Be Needed
You would need to modify this regimen to include MRSA coverage if the patient had 1:
- Penetrating trauma or injection drug use
- Purulent drainage (not mentioned in your case)
- Evidence of MRSA infection elsewhere
- Systemic signs of infection (SIRS criteria)
For typical cellulitis without these features, MRSA coverage is unnecessary—β-lactam monotherapy like cephalexin is appropriate 1, 5. A 2017 trial demonstrated that adding trimethoprim-sulfamethoxazole to cephalexin provided no additional benefit for uncomplicated cellulitis 5.
Monitoring and Follow-up
Ensure the patient:
- Elevates the affected extremity to promote drainage 1
- Returns if no improvement within 48-72 hours
- Completes the full antibiotic course even if feeling better early 2
- Is assessed for predisposing factors like venous insufficiency, lymphedema, or obesity 1
Common Pitfall to Avoid
Do not assume MRSA is the causative pathogen in typical cellulitis. Despite rising community MRSA rates, β-hemolytic streptococci remain the predominant cause of non-purulent cellulitis, and β-lactams like cephalexin achieve cure rates exceeding 95% 1, 6. Overuse of broader-spectrum antibiotics contributes to resistance without improving outcomes.